enkephalinamide-met, ala(2)- has been researched along with alprostadil in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bidlack, JM; Hemmick, LM | 1 |
| Greenspan, DL; Musacchio, JM | 1 |
| Hallermayer, K; Hamprecht, B; Harmening, C; Merz, H | 1 |
3 other study(ies) available for enkephalinamide-met, ala(2)- and alprostadil
| Article | Year |
|---|---|
Endorphin peptides enhance mitogen-induced T cell proliferation which has been suppressed by prostaglandins.
Topics: Alprostadil; Animals; beta-Endorphin; Cells, Cultured; Concanavalin A; Enkephalin, Methionine; Lymphocyte Activation; Male; Phytohemagglutinins; Rats; Rats, Inbred Strains; T-Lymphocytes | 1991 |
The adenylate cyclase rebound response to naloxone in the NG108-15 cells. Effects of etorphine and other opiates.
Topics: Adenylyl Cyclases; Alprostadil; Cell Line; Enkephalin, Leucine; Enkephalin, Leucine-2-Alanine; Enkephalin, Methionine; Etorphine; Glioma; Morphinans; Morphine; Naloxone; Neuroblastoma; Receptors, Opioid | 1986 |
Irreversible activation of the opiate receptor of neuroblastoma X glioma hybrid cells by an alkylating benzomorphan derivative.
Topics: Affinity Labels; Alprostadil; Animals; Benzomorphans; Cells, Cultured; Cyclic AMP; Dose-Response Relationship, Drug; Enkephalin, Methionine; Glioma; Hybrid Cells; Morphinans; Neuroblastoma; Prostaglandins E; Receptors, Opioid | 1983 |